Rosalind G. Brewer - 29 Mar 2023 Form 4 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
31 Mar 2023, 16:26:50 UTC
Prior SEC filing
17 Mar 2023
Next SEC filing
08 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rosalind G. Brewer by Paul Ingram, Attorney-in-Fact

Key filing fact

Rosalind G. Brewer filed Form 4 for Walgreens Boots Alliance, Inc. (WBA) on 31 Mar 2023.

Key facts

  • This page summarizes Rosalind G. Brewer's Form 4 filing for Walgreens Boots Alliance, Inc. (WBA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Mar 2023, 16:26.

Change

  • Previous filing in this sequence was filed on 17 Mar 2023.
  • Current net transaction value: +$339,510.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WBA transaction

Common Stock

Purchase

Transaction value
$339,510
Shares
+10,000
Change %
+2.8%
Price
$33.95
Shares after
369,945
Date
29 Mar 2023
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.76 to $34.13, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated.

Footnote F2

Includes shares underlying restricted stock units issued in lieu of dividends (through March 30, 2023) on outstanding restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .